This post is from a suggested group
Recombinant DNA Technology: Innovations in Genetic Engineering and Biopharmaceutical Development
Recombinant DNA technology refers to techniques used to manipulate DNA sequences to produce desired proteins, vaccines, or other therapeutic agents. It has revolutionized biotechnology, enabling the development of insulin, growth hormones, monoclonal antibodies, and gene therapies.
Overview and Applications
The technology allows insertion, deletion, or modification of genetic material in microorganisms, plants, or mammalian cells. Pharmaceutical and agricultural sectors rely heavily on recombinant DNA for therapeutic protein production, crop improvement, and disease-resistant strains. Advances in CRISPR-Cas systems and vector design have enhanced precision, efficiency, and scalability.
Regulatory compliance and quality assurance are critical, as recombinant DNA products must meet stringent safety standards. Automated gene editing platforms, high-throughput screening, and bioinformatics tools are streamlining the research and development pipeline.
